SHANGHAI -- Shares in the main pharmaceuticals unit of Chinese conglomerate Fosun International rose sharply on Tuesday as investors applauded its role in what could be a breakthrough global COVID-19 vaccine.
Coronavirus
Investors applaud Fosun role in promising Pfizer COVID vaccine
Unit of Chinese conglomerate has partnered with Germany's BioNTech
Read Next
Latest on Coronavirus
